You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,342,780


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,342,780 protect, and when does it expire?

Patent 10,342,780 protects JAYPIRCA and is included in one NDA.

This patent has seventy-four patent family members in thirty-eight countries.

Summary for Patent: 10,342,780
Title:Compounds useful as kinase inhibitors
Abstract:This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
Inventor(s):Guisot Nicolas
Assignee:Loxo Oncology, Inc.
Application Number:US16109162
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,342,780

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Loxo Oncol JAYPIRCA pirtobrutinib TABLET;ORAL 216059-001 Jan 27, 2023 RX Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Loxo Oncol JAYPIRCA pirtobrutinib TABLET;ORAL 216059-002 Jan 27, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,342,780

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3390395 ⤷  Sign Up CA 2024 00006 Denmark ⤷  Sign Up
European Patent Office 3390395 ⤷  Sign Up 301262 Netherlands ⤷  Sign Up
European Patent Office 3390395 ⤷  Sign Up LUC00330 Luxembourg ⤷  Sign Up
European Patent Office 3390395 ⤷  Sign Up PA2024506 Lithuania ⤷  Sign Up
European Patent Office 3390395 ⤷  Sign Up CR 2024 00006 Denmark ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.